Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
7.22
-0.90 (-11.08%)
Nov 18, 2024, 3:07 PM EST - Market open

Camp4 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022
Period Ending
Nov '24 Dec '23 Dec '22
Market Capitalization
141--
Enterprise Value
318--
Debt / Equity Ratio
0.700.320.15
Asset Turnover
-0.00-
Quick Ratio
1.664.9710.55
Current Ratio
1.905.1310.62
Return on Equity (ROE)
--80.13%-
Return on Assets (ROA)
--41.18%-
Return on Capital (ROIC)
--43.93%-
Buyback Yield / Dilution
-26.47%-
Total Shareholder Return
-26.47%-
Source: S&P Capital IQ. Standard template. Financial Sources.